Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.24308PMID 21425314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysis

  2011cited by this paper
• Chronic hepatitis B : an update

  2010cited by this paper
• Chronic hepatitis B: Update 2009

  2009cited by this paper
• Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment

  2008cited by this paper
• Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.

  2007cited by this paper
• Virological Profiles in Hepatitis B Virus/Hepatitis C Virus Coinfected Patients under Interferon plus Ribavirin Therapy

  2006cited by this paper
• Epidemiology and Natural History of Hepatitis B

  2005cited by this paper
• [Epidemiology and natural history of hepatitis B].

  2005cited by this paper
• Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.

  2004cited by this paper
• Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers

  2004cited by this paper
• Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases.

  2003cited by this paper
• Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study.

  2003cited by this paper
• HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course

  2002cited by this paper
• Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection.

  2002cited by this paper
• Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

  2000cited by this paper
• Hepatitis B genotypes and the response to interferon therapy.

  2000cited by this paper
• Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B.

  2000cited by this paper
• Hepatitis C--global prevalence (update).

  2000cited by this paper
• Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis

  1999cited by this paper
• Hepatitis C--global prevalence (update).

  1999cited by this paper
• Characteristics of patients with dual infection by hepatitis B and C viruses.

  1998cited by this paper
• Low-Level Viremia and Intracellular Expression of Hepatitis B Surface Antigen (HBsAg) in HBsAg Carriers with Concurrent Hepatitis C Virus Infection

  1998cited by this paper
• Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients.

  1997cited by this paper
• The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks.

  1997cited by this paper
• Hepatitis B virus infection.

  1997cited by this paper
• Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA.

  1996cited by this paper
• Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

  1995cited by this paper
• Role of hepatitis C virus in dual and triple hepatitis virus infection

  1995cited by this paper
• Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment

  1995cited by this paper
• Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.

  1995cited by this paper
• Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study.

  1994cited by this paper
• Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

  1994cited by this paper
• Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.

  1994cited by this paper
• Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

  1994cited by this paper
• Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients.

  1994cited by this paper
• Coinfection of hepatitis C virus in patients with chronic hepatitis B infection.

  1994cited by this paper
• Clinical and virological profiles in patients with multiple hepatitis virus infections.

  1993cited by this paper
• The significance of antibody to hepatitis C virus in patients with chronic hepatitis B

  1991cited by this paper
• Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.

  1991cited by this paper
• Hepatitis C virus infection in chronic hepatitis B virus carriers.

  1991cited by this paper
• Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection.

  1987cited by this paper
• Two distinct types of hepatitis in experimental hepatitis B virus infection.

  1980cited by this paper

• SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024

  2024cites this paper
• Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment

  2022cites this paper
• Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection

  2021cites this paper
• Treatment of HCV, HDV, or HIV Coinfections

  2021cites this paper
• We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases

  2021cites this paper
• Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections.

  2020cites this paper
• Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

  2020cites this paper
• Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection

  2020cites this paper
• Management of hepatitis B and hepatitis C coinfection: an expert review

  2020cites this paper
• When viruses collide: hepatitis B virus reactivation after hepatitis C treatment.

  2020cites this paper
• Hepatitis B Virus Reactivation Potentiated by Biologics.

  2020cites this paper
• Viral Hepatitis: Chronic Hepatitis C

  2019cites this paper
• Treatment of Hepatitis C Virus in Special Populations (HBV Coinfection, Drug Users, and Prisoners)

  2019cites this paper
• Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues

  2018cites this paper
• A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

  2018cites this paper
• Treatment of HCV, HDV, or HIV Coinfection

  2018cites this paper
• An update on the treatment options for HBV/HCV coinfection

  2017cites this paper
• Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

  2017cites this paper
• Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma

  2017cites this paper
• Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus

  2017cites this paper
• Chronic Hepatitis B Reactivation Subsequent to Chronic Hepatitis C Treatment: A Case Report

  2017cites this paper
• HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection

  2016cites this paper
• Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia

  2016cites this paper
• COMPARISON OF HCV TREATMENT; HCV MONO-INFECTED AND HCV/HBV CO-INFECTED PATIENTS.

  2016cites this paper
• Perspectives on dual hepatitis B and C infection in Taiwan.

  2016cites this paper
• The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management

  2015cites this paper
• Epidemiological Aspects of Hepatitis B and Prognostic Factors of Cirrhosis in Patients with Chronic Hepatitis B in the Western Amazon

  2015influential citation
• Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?

  2015cites this paper
• MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

  2015cites this paper
• Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection

  2014cites this paper
• Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.

  2014cites this paper
• Hepatitis B virus and hepatitis C virus dual infection.

  2014cites this paper
• Management of Chronic Hepatitis C among Asian Americans

  2014cites this paper
• Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma

  2014cites this paper
• Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues

  2014cites this paper
• Systematic review: Asian patients with chronic hepatitis C infection

  2013cites this paper
• Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge.

  2013cites this paper
• Treatment of patients with dual hepatitis B and C: a step in the right direction

  2013cites this paper
• Management of hepatitis C in HIV and/or HBV co-infected patients.

  2012cites this paper
• Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy

  2012cites this paper
• Prioritizing treatment experienced patients with hepatitis C infection for treatment with telaprevir: A number needed to treat approach

  2012cites this paper
• Identification of endogenous normalizers for serum MicroRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer

  2012cites this paper